• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
FDA stop sign
Biotech

Senior FDA official fires back at uniQure amid controversy

A senior FDA official said the agency never agreed with uniQure's plan, saying “the FDA will always say, ‘Well, we have to see the data when we get it.’”
Angus Liu , Darren Incorvaia Mar 5, 2026 3:33pm
team layoffs workforce

Alltrna lays off 35% of staffers

Mar 5, 2026 12:40pm
How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society
tennis racket hitting ball

UniQure, FDA back-and-forth intensifies

Mar 5, 2026 11:55am
Pipette dripping water droplet with money symbol on it into test tube

Tenaya, Alnylam ink collab to find gene targets for cardio drugs

Mar 5, 2026 10:56am
eyeball

Science closes major $230M series C round

Mar 5, 2026 10:50am
More News

VC firm to open 30K-square-foot incubator in Salt Lake City

Mar 5, 2026 10:00am

Daiichi pens pact for high cholesterol digital therapeutic

Mar 5, 2026 9:20am

Fierce Biotech Layoff Tracker 2026: Alltrna, EveryOne & more

Mar 5, 2026 8:00am

Guardant hits the road with colon cancer blood test

Mar 5, 2026 5:50am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings